Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Targeting tropomyosin receptor kinase in cutaneous CYLD defective tumors with pegcantratinib: The TRAC randomized clinical trial. Have a read: https://www.m3india.in/contents/journal/targeting-tropomyosin-receptor-kinase-in?utm_campaign=unset&utm_medium=share&utm_source=ref_wa